They found that the improvement in OS was only marginally statistically significant in patients receiving TKIs therapy, which was similar to our conclusion [ 7 , 8 ].
← all excerpts
Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
1
—
—